It was a long time coming, but the US FDA is finally taking the peddlers of the latest ineffective stretch mark "cure" (by Basic Research, LLC and registered to another entity) to task for having duped the public by making its product out to be a proven over the counter drug.
While a trite "thirty day 100% money back guarantee" is offered, a clear explanation that stretch marks are scarred tears in the dermis is not. That's not something you can fix in thirty days, if ever.
One year's treatment will cost around US $540.00 or AUD $960.00 going by Australian pricing. The appearance of a reduction in stretch marks this product may achieve by softening skin would be dependent on ongoing use (three times daily is indicated by the manufacturer).
Determining whether or not it will work for you, which we hold it wouldn't, would be an expensive affair outside protection offered by the guarantee.
In recent times, and following US FDA probing, Basic Research has been marketing Strivectin-SD as a general facial wrinkle cream, an eye cream and now even a hand cream. They claim this use was accidentally discovered after users "became confused" and started applying it to their faces.
Either there's nothing the formula can't ultimately purport to do, or Basic Research senses the imminent death of their ability to market outlandish cures for stretch marks.
Wrinkle and hand creams are far more familiar legal territories to safely navigate.